New research from Tokyo, Japan could help clarify the role of proinflammatory mediators in the pathogenesis of chronic inflammatory myopathies, such as polymyositis and dermatomyositis.

Idiopathic forms are rarely associated with polymyositis, 4 but a much stronger correlation exists in the presence of a thymoma, particularly in those with myocardial involvement, when anti-titin ...

Department of Rheumatology, Northwick Park Hospital, Harrow, Middlesex. The distinction between polymyalgia rheumatica and polymyositis is important for treatment and prognosis. Four elderly patients ...

The inflammatory myopaties such as polymyositis (PM) and dermatomyositis (DM) are autoimmune inflammatory muscle disorders characterised by the development of proximal and often symmetrical muscle ...

However, its usefulness in evaluating muscle lesions in polymyositis and dermatomyositis syndromes (PM/DM) has not been established. Methods 33 patients with PM/DM who had undergone FDG PET were ...

Keep abreast with the latest news related to Polymyositis there are 13 news items on Polymyositis that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable ...

Objectives Risk prediction for patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD) is challenging due to heterogeneity in the ...

ULSCs is under clinical development by RESTEM and currently in Phase I for Polymyositis. According to GlobalData, Phase I drugs for Polymyositis does not have sufficient historical data to build an ...

She had positive antinuclear antibodies, antineutrophil cytoplasmic antibody and myositis panel. The elevation of troponins was attributed to polymyositis and treated with methotrexate and prednisone ...

Read More on PubMed Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Oddis CV. Chester V; Reed AM. Ann M; Aggarwal ...